75 related articles for article (PubMed ID: 11073110)
1. Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits neutrophil recruitment in the lung triggered by fMLP.
Raiden S; Pereyra Y; Nahmod V; Alvarez C; Castello L; Giordano M; Geffner J
J Leukoc Biol; 2000 Nov; 68(5):700-6. PubMed ID: 11073110
[TBL] [Abstract][Full Text] [Related]
2. Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits the binding of N-formylmethionyl-leucyl-phenylalanine to neutrophil receptors.
Raiden S; Giordano M; Andonegui G; Trevani AS; López DH; Nahmod V; Geffner JR
J Pharmacol Exp Ther; 1997 May; 281(2):624-8. PubMed ID: 9152365
[TBL] [Abstract][Full Text] [Related]
3. Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome.
Raiden S; Nahmod K; Nahmod V; Semeniuk G; Pereira Y; Alvarez C; Giordano M; Geffner JR
J Pharmacol Exp Ther; 2002 Oct; 303(1):45-51. PubMed ID: 12235231
[TBL] [Abstract][Full Text] [Related]
4. Losartan attenuates ventilator-induced lung injury.
Yao S; Feng D; Wu Q; Li K; Wang L
J Surg Res; 2008 Mar; 145(1):25-32. PubMed ID: 17688881
[TBL] [Abstract][Full Text] [Related]
5. Peripheral administration of AT1 receptor blockers and pressor responses to central angiotensin II and sodium.
Zhang J; Leenen FH
Can J Physiol Pharmacol; 2001 Oct; 79(10):861-7. PubMed ID: 11697745
[TBL] [Abstract][Full Text] [Related]
6. Decreased binding sites of angiotensin II in rat LY-80 and AH109A tumour and human gastric cancer using quantitative in vitro autoradiography.
Kohzuki M; Tanda S; Hori K; Suzuki M; Yoshida K; Sato T
Int Angiol; 2000 Mar; 19(1):52-8. PubMed ID: 10853686
[TBL] [Abstract][Full Text] [Related]
7. Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat.
Liu L; Qiu HB; Yang Y; Wang L; Ding HM; Li HP
Arch Biochem Biophys; 2009 Jan; 481(1):131-6. PubMed ID: 18940180
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor antagonist blocks the expression of connexin43 induced by cyclical mechanical stretch in cultured neonatal rat cardiac myocytes.
Shyu KG; Chen CC; Wang BW; Kuan P
J Mol Cell Cardiol; 2001 Apr; 33(4):691-8. PubMed ID: 11273722
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
11. AT1 receptor antagonism ameliorates acute pancreatitis-associated pulmonary injury.
Chan YC; Leung PS
Regul Pept; 2006 Mar; 134(1):46-53. PubMed ID: 16443293
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats.
Gibot S; Alauzet C; Massin F; Sennoune N; Faure GC; Béné MC; Lozniewski A; Bollaert PE; Lévy B
J Infect Dis; 2006 Oct; 194(7):975-83. PubMed ID: 16960786
[TBL] [Abstract][Full Text] [Related]
13. Angiotensins II and IV stimulate the rat adrenocortical cell proliferation acting via different receptors.
Pawlikowski M; Gruszka A; Mucha S; Melen-Mucha G
Endocr Regul; 2001 Sep; 35(3):139-42. PubMed ID: 11674842
[TBL] [Abstract][Full Text] [Related]
14. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
15. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S
Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485
[TBL] [Abstract][Full Text] [Related]
17. Sympatho-inhibitory properties of various AT1 receptor antagonists.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin II microinjected into medial amygdala on male sexual behavior in rats.
Breigeiron MK; Morris M; Lucion AB; Sanvitto GL
Horm Behav; 2002 May; 41(3):267-74. PubMed ID: 11971660
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between AT(1) and AT(2) angiotensin receptors in rat anococcygeus smooth muscle.
de Godoy MA; de Oliveira AM
J Pharmacol Exp Ther; 2002 Oct; 303(1):333-9. PubMed ID: 12235268
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase D-dependent and -independent p38MAPK activation pathways are required for superoxide production and chemotactic induction, respectively, in rat neutrophils stimulated by fMLP.
Azuma Y; Kosaka K; Kashimata M
Eur J Pharmacol; 2007 Jul; 568(1-3):260-8. PubMed ID: 17560994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
